UK markets closed

Hikma Pharmaceuticals PLC (HIK.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
1,958.00-1.00 (-0.05%)
At close: 04:35PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 4.34B
Enterprise value 5.10B
Trailing P/E 29.24
Forward P/E 12.35
PEG ratio (5-yr expected) 2.38
Price/sales (ttm)1.92
Price/book (mrq)2.51
Enterprise value/revenue 2.25
Enterprise value/EBITDA 11.73

Trading information

Stock price history

Beta (5Y monthly) 0.44
52-week change 35.75%
S&P500 52-week change 326.14%
52-week high 32,222.00
52-week low 30.00
50-day moving average 31,895.42
200-day moving average 31,922.12

Share statistics

Avg vol (3-month) 3553.26k
Avg vol (10-day) 3259.6k
Shares outstanding 5221.88M
Implied shares outstanding 6221.88M
Float 8154.66M
% held by insiders 130.62%
% held by institutions 137.63%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.57
Forward annual dividend yield 42.93%
Trailing annual dividend rate 30.72
Trailing annual dividend yield 30.04%
5-year average dividend yield 41.99
Payout ratio 472.75%
Dividend date 3N/A
Ex-dividend date 421 Mar 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 6.61%
Operating margin (ttm)21.41%

Management effectiveness

Return on assets (ttm)8.46%
Return on equity (ttm)8.81%

Income statement

Revenue (ttm)2.88B
Revenue per share (ttm)13.02
Quarterly revenue growth (yoy)11.00%
Gross profit (ttm)N/A
Net income avi to common (ttm)190M
Diluted EPS (ttm)0.67
Quarterly earnings growth (yoy)293.30%

Balance sheet

Total cash (mrq)229M
Total cash per share (mrq)1.04
Total debt (mrq)1.19B
Total debt/equity (mrq)53.92%
Current ratio (mrq)1.57
Book value per share (mrq)9.94

Cash flow statement

Operating cash flow (ttm)608M
Levered free cash flow (ttm)445.25M